Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma

BACKGROUND: Standard therapy for patients with stage I-III squamous cell carcinoma (SCC) of the anal canal is chemo-radiotherapy with 5-fluorouracil (5-FU) and mitomycin C (MMC). While there is limited published evidence to substitute capecitabine (CAP) for 5-FU, the objectives of the study were to...

Descripción completa

Detalles Bibliográficos
Autores principales: Thind, Govin, Johal, Bal, Follwell, Matthew, Kennecke, Hagen Fritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050390/
https://www.ncbi.nlm.nih.gov/pubmed/24885554
http://dx.doi.org/10.1186/1748-717X-9-124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050390/
https://www.ncbi.nlm.nih.gov/pubmed/24885554
http://dx.doi.org/10.1186/1748-717X-9-124

Ejemplares similares